Responses
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature
Compose a Response to This Article
Other responses
No responses have been published for this article.